Skip to content

Drug interactions

Buspirone + Dihydroergotamine intranasal

Severity: Moderate

Buspirone and Dihydroergotamine intranasal: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Intranasal dihydroergotamine has serotonin receptor agonist activity that might add to the serotonergic effects of buspirone. Reports of serotonin syndrome are limited and the significance is uncertain.

What this interaction means in plain words

Buspirone and Dihydroergotamine intranasal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Possible additive serotonergic activity at 5-HT receptors.

What to do

Monitor for signs of serotonin toxicity after dosing. Stop one agent if symptoms occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buspirone and Dihydroergotamine intranasal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buspirone with Dihydroergotamine intranasal?

MediHelp rates the interaction as moderate. Buspirone and Dihydroergotamine intranasal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Intranasal dihydroergotamine has serotonin receptor agonist activity that might add to the serotonergic effects of buspirone. Reports of serotonin syndrome are limited and the significance is uncertain.

How serious is the interaction between Buspirone and Dihydroergotamine intranasal?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of serotonin toxicity after dosing. Stop one agent if symptoms occur.

What other medicines interact with Buspirone?

MediHelp also lists interactions of Buspirone with, for example, Isocarboxazid, Linezolid, Phenelzine. The full list is on the Buspirone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in